Synergistic methods and compositions for treating cancer
AssigneeBristol-Myers Squibb Company
InventorFrancis Y. Lee
Life of this patent
Estimating the term…
Abstract
The present invention provides a synergistic method for the treatment of cancer which comprises administering to a mammalian specie in need thereof a synergistically, therapeutically effective amount of: (1) at least agent selected from the group consisting of cytotoxic agents and cytostatic agents, and (2) a compound of formula I 1 or a pharmaceutically acceptable salt thereof. The present invention further provides a pharmaceutical composition for the synergistic treatment of cancer which comprises at least one agent selected from the group consisting of antiproliferative cytotoxic agents and antiproliferative cytostatic agents, a compound of formula I, and a pharmaceutically acceptable carrier.
Claims53
A method for the treatment of cancer which comprises administering to a mammalian specie in need thereof a synergistically, therapeutically effective amount of (1) at least one agent selected from the group consisting of anti-proliferative cytotoxic agents and cytostatic agents and (2) a compound of formula I
- 15
- or a pharmaceutically acceptable salt thereof wherein
- R1 is Cl, Br, CN, optionally substituted phenyl, or optionally substituted 2-,3- or 4-pyridyl;
- R2 is optionally substituted lower alkyl, or optionally substituted aralkyl;
- R3 and R5 are each independently optionally substituted lower alkyl, optionally substituted aryl, or optionally substituted heterocyclo;
- R4 is hydrogen or lower alkyl;
- Z1 is CO, SO2, CO2 or SO2N(R5)—;
- and
- n is 1 or 2;
- provided that the cytotoxic agent and/or cytostatic agent is administered simultaneously with or prior to the formula I compound.
Dependencies are inferred from the claim text.